Answer
The mean terminal half-life of adalimumab was approximately two weeks after intravenous doses of 0.5 mg/kg (approximately 40 mg).
Sources for this answer
- Humira 40 mg solution for injection in pre-filled pen (Great Britain)AbbVie Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 24Document updated
Sources checked